Event and Time
Event Description
This case revolves around representative proceedings initiated against RCR Tomlinson Ltd (in liquidation) and its former directors, Dr. Paul Dalgleish and Bruce James. The plaintiffs accused them of misleading and deceptive conduct connected with the company’s continuous disclosure obligations prior to its administration.
Application and Claims
The plaintiffs sought to settle claims under section 173 of the Civil Procedure Act 2005 (NSW), believing that Dr. Dalgleish and Mr. James misled the market regarding RCR's financial health and sustainability through various public statements made between 2017 and 2018.
Judicial Decisions
The court approved the settlement reached with both Dr. Dalgleish and Mr. James, determining that the settlement was fair and reasonable given the circumstances and potential outcomes of the underlying claims.
Dispute Points and Legal Basis
Dispute Points
- Plaintiffs’ Claims:
- Alleged that RCR breached continuous disclosure obligations. - Claimed misleading conduct by Dr. Dalgleish and Mr. James, asserting that their statements lacked reasonable grounds and constituted false or misleading representations. - Specifically highlighted statements made regarding the company's financial performance and its outlook in 2017 and 2018.
- Defendants’ Arguments:
- Dr. Dalgleish admitted making some statements but denied any misleading conduct. - Mr. James denied making the contested statement in the ASX announcement, arguing that they were general opinions and thus not misleading. - Both defendants argued that the claims against them were weaker than those against RCR itself, suggesting no additional utility in suing them. - Mr. James presented a due diligence defense under section 731 of the Corporations Act and emphasized the costs associated with continuing the claims against him.